Yıl: 2017 Cilt: 18 Sayı: 1 Sayfa Aralığı: 48 - 53 Metin Dili: İngilizce İndeks Tarihi: 29-07-2022

Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy

Öz:
Objective: Hypertrophic cardiomyopathy (HCM) as a common genetic heart disease characterized by ventricular hypertrophy and myocardial fibrosis is significantly associated with a higher risk of fatal ventricular arrhythmic events (VAEs). We aimed to assess the interval between the peak and the end of the electrocardiographic T wave (Tp–e) and Tp–e/corrected QT (QTc) ratio as candidate markers of ventricular arrhythmias in patients with HCM.Methods: In this single-center, prospective study, a total of 66 patients with HCM and 88 controls were enrolled. The patients were divided into two groups: those with VAEs (n=26) and those without VAEs (n=40). Tp–e interval and Tp–e/QTc ratio were measured using a 12-lead electrocardiogram.Results: Tp–e interval was significantly longer and Tp–e/QTc ratio were significantly higher in HCM patients than in the controls. In correlation analysis, maximal left ventricular (LV) thickness also has a significant positive correlation with Tp–e interval (r=0.422, p<0.001) and Tp–e/QTc ratio (r=0.348, p<0.001). Finally, multivariable regression analysis showed that a history of syncope, Tp–e interval [OR (odds ratio): 1.060; 95% confidence interval (CI): 1.005–1.117); p=0.012], Tp–e/QTc ratio (OR: 1.148; 95% CI: 1.086–1.204); p=0.049], and maximal LV thickness were independent predictors of VAEs in patients with HCM.Conclusion: Our findings suggested that prolonged Tp–e interval and increased Tp–e/QTc ratio may be good surrogate markers for the prediction of VAEs in HCM
Anahtar Kelime:

Konular: Kalp ve Kalp Damar Sistemi
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • Maron BJ. Hypertrophic cardiomyopathy: an important global dis- ease. Am J Med 2004; 116: 63-5.
  • Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general popula- tion of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation 1995; 92: 785-9.
  • Konno T, Chen D, Wang L, Wakimoto H, Teekakirikul P, Nayor M, et al. Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 2010; 107: 18097-102.
  • Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and manage- ment of hypertrophic cardiomyopathy: the Task Force for the Di- agnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733- 79.
  • Todiere G, Aquaro GD, Piaggi P, Formisano F, Barison A, Masci PG, et al. Progression of myocardial fibrosis assessed with cardiac mag- netic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2012; 60: 922-9.
  • Briasoulis A, Mallikethi-Reddy S, Palla M, Alesh I, Afonso L. Myo- cardial fibrosis on cardiac magnetic resonance and cardiac out- comes in hypertrophic cardiomyopathy: a meta-analysis. Heart 2015; 101: 1406-11.
  • Konno T, Hayashi K, Fujino N, Oka R, Nomura A, Nagata Y, et al. Electrocardiographic QRS fragmentation as a marker for myocar- dial fibrosis in hypertrophic cardiomyopathy. J Cardiovasc Electro- physiol 2015; 26: 1081-7.
  • Femenía F, Arce M, Van Grieken J, Trucco E, Mont L, Abello M, et al. Fragmented QRS as a predictor of arrhythmic events in patients with hypertrophic obstructive cardiomyopathy. J Interv Card Elec- trophysiol 2013; 38: 159-65.
  • Kors JA, Ritsema van Eck HJ, van Herpen G. The meaning of the Tp-Te interval and its diagnostic value. J Electrocardiol 2008; 41: 575-80.
  • Antzelevitch C, Sicouri S, Di Diego JM, Burashnikov A, Viskin S, Shimizu W, et al. Does Tpeak-Tend provide an index of transmural dispersion of repolarization? Heart Rhythm 2007; 4: 1114-6.
  • Akboğa MK, Yüksel M, Balcı KG, Kaplan M, Çay S, Gökbulut V, et al. Tp-e Interval, Tp-e/QTc Ratio, and Fragmented QRS Are Correlated with the Severity of Liver Cirrhosis. Ann Noninvasive Electrocardiol 2017; 22: e12359
  • Yayla Ç, Bilgin M, Akboğa MK, Gayretli Yayla K, Canpolat U, Dinç Asarcikli L, et al. Evaluation of Tp-e Interval and Tp-e/QT ratio in patients with aortic stenosis. Ann Noninvasive Electrocardiol 2016; 21: 287-93.
  • Zhao Z, Yuan Z, Ji Y, Wu Y, Qi Y. Left ventricular hypertrophy ampli- fies the QT, and Tp-e intervals and the Tp-e/QT ratio of left chest ECG. J Biomed Res 2010; 24: 69-72.
  • Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2011; 124: e783-831.
  • Debonnaire P, Katsanos S, Joyce E, VAN DEN Brink OV, Atsma DE, Schalij MJ, et al. QRS fragmentation and QTc duration relate to ma- lignant ventricular tachyarrhythmias and sudden cardiac death in patients with hypertrophic cardiomyopathy. J Cardiovasc Electro- physiol 2015; 26: 547-55.
  • Smetana P, Schmidt A, Zabel M, Hnatkova K, Franz M, Huber K, et al. Assessment of repolarization heterogeneity for prediction of mor- tality in cardiovascular disease: Peak to the end of the T wave in- terval and nondipolar repolarization components. J Electrocardiol 2011; 44: 301-8.
  • Erikssen G, Liestol K, Gullestad L, Haugaa KH, Bendz B, Amlie JP. The terminal part of the QT interval (T peak to T end): A predictor of mortality after acute myocardial infarction. Ann Noninvasive Elec- trocardiol 2012; 17: 85-94.
  • Zehir R, Karabay CY, Kalaycı A, Akgün T, Kılıçgedik A, Kırma C. Evaluation of Tpe interval and Tpe/QT ratio in patients with slow coronary flow. Anatol J Cardiol 2015; 15: 463-7.
  • Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, et al. T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocar- diol 2008; 41: 567-74.
  • Johnson JN, Grifoni C, Bos JM, Saber-Ayad M, Ommen SR, Nistri S, et al. Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy. Eur Heart J 2011; 32: 1114-20.
  • Jouven X, Hagege A, Charron P, Carrier L, Dubourg O, Langlard JM, et al: Relation between QT duration and maximal wall thickness in familial hypertrophic cardiomyopathy. Heart 2002; 88: 153-7.
  • Poliac LC, Barron ME, Maron BJ. Hypertrophic cardiomyopathy. Anesthesiology 2006; 104: 183-92.
  • Camici PG, Olivotto I, Rimoldi OE. The coronary circulation and blood flow in left ventricular hypertrophy. J Mol Cell Cardiol 2012; 52: 857-64.
  • Hensley N, Dietrich J, Nyhan D, Mitter N, Yee MS, Brady M. Hyper- trophic cardiomyopathy: a review. Anesth Analg 2015; 120: 554-69.
  • Algra A, Roelandt JR, Tijssen JG, Simoons ML, Pool J. Effect of beta-blockers on the relation between QT-interval and heart rate in exercise ECG. Eur Heart J 1987; 8 Suppl D: 71-3.
  • Lin TH, Chiu HC, Lee YT, Su HM, Juo SH, Voon WC, et al. The C- allele of tissue inhibitor of metalloproteinases 2 is associated with increased magnitude of QT dispersion prolongation in elderly Chi- nese - 4-year follow-up study. Clin Chim Acta 2007; 386: 87-93.
APA Akboga M, BALCI K, YILMAZ S, AYDIN S, YAYLA Ç, ertem A, ÜNAL S, BALCI M, BALBAY Y, Aras D, topaloglu s (2017). Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. , 48 - 53.
Chicago Akboga Mehmet Kadri,BALCI KEVSER,YILMAZ Samet,AYDIN Selahattin,YAYLA ÇAĞRI,ertem Ahmet,ÜNAL Sefa,BALCI Mustafa Mücahit,BALBAY YÜCEL,Aras Dursun,topaloglu serkan Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. (2017): 48 - 53.
MLA Akboga Mehmet Kadri,BALCI KEVSER,YILMAZ Samet,AYDIN Selahattin,YAYLA ÇAĞRI,ertem Ahmet,ÜNAL Sefa,BALCI Mustafa Mücahit,BALBAY YÜCEL,Aras Dursun,topaloglu serkan Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. , 2017, ss.48 - 53.
AMA Akboga M,BALCI K,YILMAZ S,AYDIN S,YAYLA Ç,ertem A,ÜNAL S,BALCI M,BALBAY Y,Aras D,topaloglu s Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. . 2017; 48 - 53.
Vancouver Akboga M,BALCI K,YILMAZ S,AYDIN S,YAYLA Ç,ertem A,ÜNAL S,BALCI M,BALBAY Y,Aras D,topaloglu s Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. . 2017; 48 - 53.
IEEE Akboga M,BALCI K,YILMAZ S,AYDIN S,YAYLA Ç,ertem A,ÜNAL S,BALCI M,BALBAY Y,Aras D,topaloglu s "Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy." , ss.48 - 53, 2017.
ISNAD Akboga, Mehmet Kadri vd. "Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy". (2017), 48-53.
APA Akboga M, BALCI K, YILMAZ S, AYDIN S, YAYLA Ç, ertem A, ÜNAL S, BALCI M, BALBAY Y, Aras D, topaloglu s (2017). Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. The Anatolian Journal of Cardiology, 18(1), 48 - 53.
Chicago Akboga Mehmet Kadri,BALCI KEVSER,YILMAZ Samet,AYDIN Selahattin,YAYLA ÇAĞRI,ertem Ahmet,ÜNAL Sefa,BALCI Mustafa Mücahit,BALBAY YÜCEL,Aras Dursun,topaloglu serkan Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. The Anatolian Journal of Cardiology 18, no.1 (2017): 48 - 53.
MLA Akboga Mehmet Kadri,BALCI KEVSER,YILMAZ Samet,AYDIN Selahattin,YAYLA ÇAĞRI,ertem Ahmet,ÜNAL Sefa,BALCI Mustafa Mücahit,BALBAY YÜCEL,Aras Dursun,topaloglu serkan Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. The Anatolian Journal of Cardiology, vol.18, no.1, 2017, ss.48 - 53.
AMA Akboga M,BALCI K,YILMAZ S,AYDIN S,YAYLA Ç,ertem A,ÜNAL S,BALCI M,BALBAY Y,Aras D,topaloglu s Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. The Anatolian Journal of Cardiology. 2017; 18(1): 48 - 53.
Vancouver Akboga M,BALCI K,YILMAZ S,AYDIN S,YAYLA Ç,ertem A,ÜNAL S,BALCI M,BALBAY Y,Aras D,topaloglu s Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy. The Anatolian Journal of Cardiology. 2017; 18(1): 48 - 53.
IEEE Akboga M,BALCI K,YILMAZ S,AYDIN S,YAYLA Ç,ertem A,ÜNAL S,BALCI M,BALBAY Y,Aras D,topaloglu s "Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy." The Anatolian Journal of Cardiology, 18, ss.48 - 53, 2017.
ISNAD Akboga, Mehmet Kadri vd. "Tp-e interval and Tp-e/QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy". The Anatolian Journal of Cardiology 18/1 (2017), 48-53.